Generic Medicine Info
Should be taken on an empty stomach (i.e. At least one hour before food or two hours after food).
Special Precautions
Cerebrovascular disease, ischaemic heart disease, renal impairment, occlusive peripheral vascular disorders, history of depression. May impair ability to drive or operate machinery. Sudden withrawal may cause rebound hypertension, do not discontinue until several days after the withdrawal of β-blocker when used together.
Adverse Reactions
Drowsiness, dry mouth, dizziness, headache, constipation, depression, anxiety, fatigue, nausea, anorexia, parotid pain, sleep disturbances, vivid dreams, impotence and loss of libido, urinary retention or incontinence, slight orthostatic hypotension, fluid retention.
Drug Interactions
TCAs may antagonise the hypotensive effects of rilmenidine. Additive antihypertensive effects when used with antipsychotics and other antihypertensives. Increased sedation when used with alcohol or other CNS depressants.
CIMS Class
Other Antihypertensives
ATC Classification
C02AC06 - rilmenidine ; Belongs to the class of imidazoline receptor agonists, centrally-acting antiadrenergic agents. Used in the treatment of hypertension.
Disclaimer: This information is independently developed by CIMS based on rilmenidine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in